Global Oligonucleotide Pool Library Market

Oligonucleotide Pool Library Comprehensive Study by Type (12K Different Oligo per Pools, 90K Different Oligo per Pools, Other), Application (Target Capture, CRISPR/Cas9 Designs, Gene Synthesis, Library Preparation, Other) Players and Region - Global Market Outlook to 2028

Oligonucleotide Pool Library Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Oligonucleotide Pool Library Market Scope
Oligonucleotide pools are a highly diverse collection of single-stranded oligonucleotides synthesized using silicon-based DNA writing technology. Oligo pools are utilized in various applications such as the generation of CRISPR guide RNA (sgRNA) libraries, peptide screens, protein screens, and high-throughput reporter assays. CRISPR guide RNA (sgRNA) libraries are for cloning into expression vectors. Accuracy and uniformity of oligo synthesis are critical to ensure the specificity of targeting and oligo representation.



The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Oligonucleotide Pool Library market throughout the predicted period.

Agilent Technology (United States), Eurogentec S.A (Kaneka Corporation) (Belgium), Merck Group (Sigma Aldrich) (Germany), Illumnia Inc. (United States), LGC Biosearch Technologies (United States), Eurofins Genomics (Germany), Roche Sequencing (United States), Integrated DNA Technologies (United States), Nitto Denko Avecia Inc (United States) and General Biosystems (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Arbor Biosciences (United States), Twist Bioscience (United States), Genscript Biotech (United States), LC Sciences (United States) and Creative Biogene (United States).

Segmentation Overview
The study have segmented the market of Global Oligonucleotide Pool Library market by Type (12K Different Oligo per Pools, 90K Different Oligo per Pools and Other), by Application (Target Capture, CRISPR/Cas9 Designs, Gene Synthesis, Library Preparation and Other) and Region with country level break-up.

On the basis of geography, the market of Oligonucleotide Pool Library has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Increasing demand for oligonucleotide pool libraries, due to their extensive applications in research, diagnostics, therapeutics, and biotechnology

Market Growth Drivers:
Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications and Subsequent Improvements in Oligonucleotide Synthesis

Challenges:
Large-Scale Synthesis of Oligos and Delivery of Oligonucleotide Drugs to Specific Targets

Restraints:
Price Erosion of Synthesized Oligos and Lack of A Unified Set of Regulations for therapeutic Oligos

Opportunities:
Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies and Rise in Venture Capital Investments in Developed Economies

Market Leaders and their Expansionary Development Strategies

In February 2019, Thermo Fisher Scientific entered into an agreement with BioNTech (Germany). Through this agreement, BioNTech's messenger RNA (mRNA) manufacturing platform will be supported by Thermo Fisher through the supply of nucleotides, enzymes, and other critical raw materials.


Key Target Audience
Oligonucleotide Pool Library Providers, Bio-Medical Research Organisation, Government and Private Organisation, End User and Others

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • 12K Different Oligo per Pools
  • 90K Different Oligo per Pools
  • Other
By Application
  • Target Capture
  • CRISPR/Cas9 Designs
  • Gene Synthesis
  • Library Preparation
  • Other
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications
      • 3.2.2. Subsequent Improvements in Oligonucleotide Synthesis
    • 3.3. Market Challenges
      • 3.3.1. Large-Scale Synthesis of Oligos
      • 3.3.2. Delivery of Oligonucleotide Drugs to Specific Targets
    • 3.4. Market Trends
      • 3.4.1. Increasing demand for oligonucleotide pool libraries, due to their extensive applications in research, diagnostics, therapeutics, and biotechnology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Oligonucleotide Pool Library, by Type, Application and Region (value) (2017-2022)
    • 5.1. Introduction
  • 6. Oligonucleotide Pool Library: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Agilent Technology (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Eurogentec S.A (Kaneka Corporation) (Belgium)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Merck Group (Sigma Aldrich) (Germany)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Illumnia Inc. (United States)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. LGC Biosearch Technologies (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Eurofins Genomics (Germany)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Roche Sequencing (United States)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Integrated DNA Technologies (United States)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Nitto Denko Avecia Inc (United States)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. General Biosystems (United States)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
  • 7. Global Oligonucleotide Pool Library Sale, by Type, Application and Region (value) (2023-2028)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Company Basic Information, Sales Area and Its Competitors
  • Table 11. Research Programs/Design for This Report
  • Table 12. Key Data Information from Secondary Sources
  • Table 13. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Agilent Technology (United States) Revenue, Net Income and Gross profit
  • Figure 5. Agilent Technology (United States) Revenue: by Geography 2022
  • Figure 6. Eurogentec S.A (Kaneka Corporation) (Belgium) Revenue, Net Income and Gross profit
  • Figure 7. Eurogentec S.A (Kaneka Corporation) (Belgium) Revenue: by Geography 2022
  • Figure 8. Merck Group (Sigma Aldrich) (Germany) Revenue, Net Income and Gross profit
  • Figure 9. Merck Group (Sigma Aldrich) (Germany) Revenue: by Geography 2022
  • Figure 10. Illumnia Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 11. Illumnia Inc. (United States) Revenue: by Geography 2022
  • Figure 12. LGC Biosearch Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 13. LGC Biosearch Technologies (United States) Revenue: by Geography 2022
  • Figure 14. Eurofins Genomics (Germany) Revenue, Net Income and Gross profit
  • Figure 15. Eurofins Genomics (Germany) Revenue: by Geography 2022
  • Figure 16. Roche Sequencing (United States) Revenue, Net Income and Gross profit
  • Figure 17. Roche Sequencing (United States) Revenue: by Geography 2022
  • Figure 18. Integrated DNA Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 19. Integrated DNA Technologies (United States) Revenue: by Geography 2022
  • Figure 20. Nitto Denko Avecia Inc (United States) Revenue, Net Income and Gross profit
  • Figure 21. Nitto Denko Avecia Inc (United States) Revenue: by Geography 2022
  • Figure 22. General Biosystems (United States) Revenue, Net Income and Gross profit
  • Figure 23. General Biosystems (United States) Revenue: by Geography 2022
List of companies from research coverage that are profiled in the study
  • Agilent Technology (United States)
  • Eurogentec S.A (Kaneka Corporation) (Belgium)
  • Merck Group (Sigma Aldrich) (Germany)
  • Illumnia Inc. (United States)
  • LGC Biosearch Technologies (United States)
  • Eurofins Genomics (Germany)
  • Roche Sequencing (United States)
  • Integrated DNA Technologies (United States)
  • Nitto Denko Avecia Inc (United States)
  • General Biosystems (United States)
Additional players considered in the study are as follows:
Arbor Biosciences (United States) , Twist Bioscience (United States) , Genscript Biotech (United States) , LC Sciences (United States) , Creative Biogene (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 234 Pages 80 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Oligonucleotide Pool Library Market Quantitative research analysis
Global Oligonucleotide Pool Library Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Oligonucleotide Pool Library study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Oligonucleotide Pool Library Market is gaining popularity and expected to see strong valuation by 2028 .
According to AMA, the Global Oligonucleotide Pool Library market is expected to see growth rate of xx%.
The Oligonucleotide Pool Library market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Oligonucleotide Pool Library Market Report?

Have a Query? Click Here

Other Related Reports

Microalgae Comprehensive Study by Type (Spirulina, Chlorella, Arthrospira, Tetraselmis, Others), Application (Food and Feed, Pharmaceuticals, Biofuels), Compounds (Pigments, Fatty acids, Anti-oxidant...
$ 3500
Pectinase Comprehensive Study by Type (Protopectinases, Polygalacturonases, Pectin Lyases, Pectinesterase), End User Industry (Food Industry, Aquaculture Industry, Winemaking Industry, Textile Indust...
$ 3350
Protein Engineering Comprehensive Study by Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors (Blood factors + Tissue plasminogen), Vaccines, Growth Factors (Hormones + Cytok...
$ 3750
Ginkgo Biloba Extract Comprehensive Study by Type (Tablets, Capsules, Liquid Extracts), Application (Food, Cosmetics, Pharmaceuticals), Distribution Channel (Offline, Online), End Use (Stroke and Oth...
$ 3650
Molecular Biology Enzymes Comprehensive Study by Type (Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Phosphatases, Proteases and Proteinases, Other Enzymes), Application (P...
$ 3750
Chitin Comprehensive Study by Type (Beta Chitin, Alpha Chitin), Application (Agriculture, Industrial, Medicine, Others), Darivatives (Glucosamine, Chitosan) Players and Region - Global Market Outlook...
$ 3500